Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms

Surgery

Volumn 138, Issue 6, 2005, Pages 1102-1110

  Kebebew, Electron ^a,b   Peng, Miao ^b   Reiff, Emily ^b   Duh, Quan Yang ^b   Clark, Orlo H ^a,b   McMillan, Alex ^a   Singh, Bhuvanesh ^b   Carter, W Bradford ^b   Demeure, Michael J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ANGIOGENIC PROTEINS; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; CASE-CONTROL STUDIES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE;

EID: 29144473333     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2005.05.025     Document Type: Article

References (46)

1. A. Jemal, L.X. Clegg, E. Ward, L.A. Ries, X. Wu, and P.M. Jamison Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival Cancer 101 1 2004 3 27
2. http://seer.cancer.gov/csr/1975_2001/results_merged/sect_25_thyroid.pdf. SEER Cancer Statistics Review 1975-2001. National Cancer Institute. Accessed on January 23, 2005.
3. R.J. Silver, and S. Parangi Management of thyroid incidentalomas Surg Clin North Am 84 3 2004 907 919
4. S. Uchino, S. Noguchi, H. Yamashita, T. Murakami, S. Watanabe, and T. Ogawa Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma World J Surg 28 11 2004 1099 1102
5. E.L. Mazzaferri Management of a solitary thyroid nodule N Engl J Med 328 8 1993 553 559
6. M.R. Castro, and H. Gharib Thyroid fine-needle aspiration biopsy: progress, practice, and pitfalls Endocr Pract 9 2 2003 128 136
7. T.S. Greaves, M. Olvera, B.D. Florentine, A.S. Raza, C.J. Cobb, and D.D. Tsao-Wei Follicular lesions of thyroid: a 5-year fine-needle aspiration experience Cancer 90 6 2000 335 341
8. Z.W. Baloch, S. Fleisher, V.A. LiVolsi, and P.K. Gupta Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology Diagn Cytopathol 26 1 2002 41 44
9. H. Gharib, and J.R. Goellner Fine-needle aspiration biopsy of the thyroid: an appraisal Ann Intern Med 118 4 1993 282 289
10. E. Cersosimo, H. Gharib, V.J. Suman, and J.R. Goellner "Suspicious" thyroid cytologic findings: outcome in patients without immediate surgical treatment Mayo Clin Proc 68 4 1993 343 348
11. H. Gharib, J.R. Goellner, and D.A. Johnson Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies Clin Lab Med 13 3 1993 699 709
12. L. Hooft, O.S. Hoekstra, M. Boers, M.W. Van Tulder, P. Van Diest, and P. Lips Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital Thyroid 14 4 2004 287 293
13. Z.W. Baloch, S. Hendreen, P.K. Gupta, V.A. LiVolsi, S.J. Mandel, and R. Weber Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules Diagn Cytopathol 25 4 2001 231 234
14. M.W. Yeh, O. Demircan, P. Ituarte, and O.H. Clark False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma Thyroid 14 3 2004 207 215
15. E. Kebebew, and O.H. Clark Differentiated thyroid cancer: "complete" rational approach World J Surg 24 8 2000 942 951
16. P.A. Treseler, and O.H. Clark Prognostic factors in thyroid carcinoma Surg Oncol Clin N Am 6 3 1997 555 598
17. E.L. Mazzaferri, R.J. Robbins, C.A. Spencer, L.E. Braverman, F. Pacini, and L. Wartofsky A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma J Clin Endocrinol Metab 88 4 2003 1433 1441
18. C.B. Barden, K.W. Shister, B. Zhu, G. Guiter, D.Y. Greenblatt, and M.A. Zeiger Classification of follicular thyroid tumors by molecular signature: results of gene profiling Clin Cancer Res 9 5 2003 1792 1800
19. D.J. Finley, B. Zhu, C.B. Barden, and T.J. Fahey 3rd Discrimination of benign and malignant thyroid nodules by molecular profiling Ann Surg 240 3 2004 425 436 discussion 36-7
20. J. Rosai Immunohistochemical markers of thyroid tumors: significance and diagnostic applications Tumori 89 5 2003 517 519
21. D.L. Segev, D.P. Clark, M.A. Zeiger, and C. Umbricht Beyond the suspicious thyroid fine needle aspirate. A review Acta Cytol 47 5 2003 709 722
22. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 6801 2000 249 257
23. D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A.F. Chambers, and M. Szabo Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J Natl Cancer Inst 94 7 2002 513 521
24. C.M. Kendziorski, Y. Zhang, H. Lan, and A.D. Attie The efficiency of pooling mRNA in microarray experiments Biostatistics 4 3 2003 465 477
25. D.G. Ginzinger Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream Exp Hematol 30 6 2002 503 512
26. Z.W. Baloch, and V.A. LiVolsi The quest for a magic tumor marker: continuing saga in the diagnosis of the follicular lesions of thyroid Am J Clin Pathol 118 2 2002 165 166
27. P.F. Jones Not just angiogenesis - wider roles for the angiopoietins J Pathol 201 4 2003 515 527
28. C.R. Tait, and P.F. Jones Angiopoietins in tumours: the angiogenic switch J Pathol 204 1 2004 1 10
29. G. Bunone, P. Vigneri, L. Mariani, S. Buto, P. Collini, and S. Pilotti Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features Am J Pathol 155 6 1999 1967 1976
30. M. Nguyen, J. Arkell, and C.J. Jackson Active and tissue inhibitor of matrix metalloproteinase-free gelatinase B accumulates within human microvascular endothelial vesicles J Biol Chem 273 9 1998 5400 5404
31. Y. Huang, M. Prasad, W.J. Lemon, H. Hampel, F.A. Wright, and K. Kornacker Gene expression in papillary thyroid carcinoma reveals highly consistent profiles Proc Natl Acad Sci U S A 98 26 2001 15044 15049
32. H. Maeta, S. Ohgi, and T. Terada Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas Virchows Arch 438 2 2001 121 128
33. H.E. Turner, A.L. Harris, S. Melmed, and J.A. Wass Angiogenesis in endocrine tumors Endocr Rev 24 5 2003 600 632
34. L.A. Akslen, A.O. Myking, H. Salvesen, and J.E. Varhaug Prognostic impact of EGF-receptor in papillary thyroid carcinoma Br J Cancer 68 4 1993 808 812
35. L.A. Akslen, and J.E. Varhaug Oncoproteins and tumor progression in papillary thyroid carcinoma: presence of epidermal growth factor receptor, c-erbB-2 protein, estrogen receptor related protein, p21-ras protein, and proliferation indicators in relation to tumor recurrences and patient survival Cancer 76 9 1995 1643 1654
36. A. Belfiore, P. Gangemi, A. Costantino, G. Russo, G.M. Santonocito, and O. Ippolito Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases J Clin Endocrinol Metab 82 7 1997 2322 2328
37. T. Fuller, T. Korff, A. Kilian, G. Dandekar, and H.G. Augustin Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells J Cell Sci 116 Pt 12 2003 2461 2470
38. X.X. Tang, A.E. Evans, H. Zhao, A. Cnaan, W. London, and S.L. Cohn High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas Clin Cancer Res 5 6 1999 1491 1496
39. H. Kataoka, M. Tanaka, M. Kanamori, S. Yoshii, M. Ihara, and Y.J. Wang Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer J Cancer Res Clin Oncol 128 7 2002 343 348
40. D.J. Finley, N. Arora, B. Zhu, L. Gallagher, and T.J. Fahey 3rd Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules J Clin Endocrinol Metab 89 7 2004 3214 3223
41. C. Mazzanti, M.A. Zeiger, N.G. Costouros, C. Umbricht, W.H. Westra, and D. Smith Using gene expression profiling to differentiate benign versus malignant thyroid tumors Cancer Res 64 8 2004 2898 2903
42. M.A. Aldred, Y. Huang, S. Liyanarachchi, N.S. Pellegata, O. Gimm, and S. Jhiang Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes J Clin Oncol 22 17 2004 3531 3539
43. E. Marshall Getting the noise out of gene arrays Science 306 5696 2004 630 631
44. N. Mah, A. Thelin, T. Lu, S. Nikolaus, T. Kuhbacher, and Y. Gurbuz A comparison of oligonucleotide and cDNA-based microarray systems Physiol Genomics 16 3 2004 361 370
45. K.B. Hwang, S.W. Kong, S.A. Greenberg, and P.J. Park Combining gene expression data from different generations of oligonucleotide arrays BMC Bioinformatics 5 1 2004 159
46. C. Sotiriou, C. Khanna, A.A. Jazaeri, D. Petersen, and E.T. Liu Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays J Mol Diagn 4 1 2002 30 36